Nicolas Lanthier

Professeur, Chef de clinique Saint-Luc

nicolas.lanthier@uclouvain.be

SSS/MEDE Faculté de médecine et médecine dentaire (MEDE)

SSS/IREC Institut de recherche expérimentale et clinique (IREC)

SSS/IREC/GAEN Pôle d'Hépato-gastro-entérologie (GAEN)

SSS/MEDE Faculté de médecine et médecine dentaire (MEDE)

2025

Article de journal

Lejeune, A., Starkel, P., Louvet, A., Hittelet, A., Bazille, C., Bastens, B., Orlent, H., Lasser, L., Dekoninck, X., Dastis, S. N., Delwaide, J., Geerts, A., Moreno, C., Galocsy, C. d., Putzeys, V., Langlet, P., Reynaert, H., Francque, S., Komuta, M., & Lanthier, N. (2025). Co-existing regeneration mechanisms in severe alcohol-related steatohepatitis. Translational Gastroenterology and Hepatology, 10(3), 1-16. https://doi.org/10.21037/tgh-24-92 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/243962

Orioli, L., Lanthier, N., Loumaye, A., & Thissen, J.-P. (2025). L’obésité sarcopénique : un phénotype particulier de l’obésité ? Medi-Sphère, 791, 24-29. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/273611

Lanthier, N., & Spahr, L. (2025). Macrophage therapy and liver regeneration: Results and perspectives. Clinics and Research in Hepatology and Gastroenterology, 49(4), 102569. https://doi.org/10.1016/j.clinre.2025.102569 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/272828

Deswysen, Y., Van den Eynde, M., & Lanthier, N. (2025). Myosteatosis in Oesophagogastric Cancer: A Systematic Review. Journal of cancer science and clinical therapeutics, 9(3), 112. https://doi.org/10.26502/jcsct.5079271 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/273615

Terken, C., Anzevui, A., Loumaye, A., & Lanthier, N. (2025). Nouveautés en nutrition clinique. Louvain médical, 144(5), 12-15. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/259443

Lanthier, N., Baldin, P., & Starkel, P. (2025). Let’s take a look at drinks, but also at solid foods. Acta Gastro-Enterologica Belgica, 88(4), 375-376. https://doi.org/10.51821/88.4.14463 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/273610

Lefere, S., Troisi, R. I., Karam, V., Fondevila, C., Nevens, F., Verbeek, J., Detry, O., Lanthier, N., Serenari, M., Wiering, L., Vanwolleghem, T., Moreno, C., Berrevoet, F., & Geerts, A. (2025). The Clinical Relevance of Prior Metabolic and Bariatric Surgery in Alcohol-Related Liver Disease in a Nationwide Belgian Liver Transplant Population. Liver international : official journal of the International Association for the Study of the Liver, 45(1), e16219. https://doi.org/10.1111/liv.16219 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/265158

Kirk, F. T., Rewitz, K. S., Mariño, Z., Couchonnal, E., Lanthier, N., Papenthin, W., Berenguer, M., Poujois, A., Debray, D., Ala, A., García-Villarreal, L., Pop, T. L., Denk, G., Socha, P., & Sandahl, T. D. (2025). Management of Wilson disease across Europe: an international physician-oriented survey by the ERN-RARE Liver group. Orphanet Journal of Rare Diseases, 20(1), 573. https://doi.org/10.1186/s13023-025-04103-6 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/273614

Lanthier, N., Annet, L., & Borbath, I. (2025). Innovations 2024 en hépato-gastroentérologie - Nouvelles recommandations concernant le carcinome hépatocellulaire. Louvain médical, 144(2), 72-74. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/259437

Stahl, K., Nalbant, B., Pape, T., Breteau, I., Coirier, V., Cardoso, F. S., de Haan, J., Janik, M. K., Wasmuth, J.-C., Madaleno, J., Merle, U., Frohme, J., Tepasse, P.-R., Müller, M., Große, K., Linke, A., Mareljic, N., Larsen, F. S., Dahlqvist, G., et al. (2025). Therapeutic plasma exchange in amatoxin associated acute liver failure–results from the multi-center Amanita-PEX study. Critical Care, 29(1), 458. https://doi.org/10.1186/s13054-025-05560-y (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/273644

Lanthier, N. (2025). Les maladies stéatosiques du foie : nouvelle nomenclature, diagnostic et évolution. Louvain médical, 144(1), 2-8. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/265160

Lanthier, N. (2025). Innovations 2024 en Hépato-Gastroentérologie - MASH et resmetirom. Louvain médical, 144(2), 70-71. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/259438

Orioli, L., Lanthier, N., Loumaye, A., & Thissen, J.-P. (2025). Is sarcopene obesitas een specifiek type van obesitas ? Medi-Sfeer, 791, 24-29. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/273613

Lanthier, N. (2025). Does the benefit of optimal MASH treatment depend on a reduction in myosteatosis? Clinics and Research in Hepatology and Gastroenterology, 49(7), 102640. https://doi.org/10.1016/j.clinre.2025.102640 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/259442

Dumont, C., Iesari, S., Baldin, P., Aydin, S., Henin, G., Philippart, M., Bonaccorsi Riani, E., Ciccarelli, O., Coubeau, L., Piessevaux, H., Lanthier, N., & Dahlqvist, G. (2025). Early diagnosis of liver graft steatosis and fibrosis: are non-invasive tests the answer? Translational Gastroenterology and Hepatology, 10, 51 [1-13]. https://doi.org/10.21037/tgh-24-131 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/271439

Delire, B., Lanthier, N., Dahlqvist, G., Deprez, P., Moreels, T., Borbath, I., Annet, L., & Horsmans, Y. (2025). Innovations 2024 en Hépato-Gastroentérologie. Louvain médical, 144(2), 67-74. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/256094

Henin, G., Goffaux, A., Declerck, S., André-Dumont, S., Pendeville, E., Valet, M., Lejeune, T., Dahlqvist, G., Loumaye, A., Schnabl, B., Starkel, P., & Lanthier, N. (2025). Non‐Cirrhotic Steatotic Liver Disease is Associated With Impaired Muscle Function: A Cross‐Sectional Study. JCSM Communications, 8(2), 1-11. https://doi.org/10.1002/rco2.70012 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/273810

Dahlqvist, G., Deprez, P., & Lanthier, N. (2025). EUS-guided portal pressure measurement: Beware of thrombosis risk. Journal of Hepatology, 83(2), e79-e80. https://doi.org/10.1016/j.jhep.2025.02.042 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/259444

Lanthier, N., & Piessevaux, H. (2025). Editorial. Louvain médical, 144(1), 1. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/244572

Lanthier, N. (2025). Dynamic imaging of macrophages in MASLD: A major interest in insulin resistance and outside the liver. JHEP Reports, 7(5), 101352. https://doi.org/10.1016/j.jhepr.2025.101352 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/259446

Papier de conférence

Lanthier, N. (2025). Nutrition intervention studies in liver cirrhosis-associated sarcopenia. 47th ESPEN congress on clinical nutrition and metabolism, Prague.

https://research.dial.uclouvain.be/handle/2078.5/259436

Prado Gonzalez, V., Debray, D., Poujois, A., & Lanthier, N. (2025). Nouveautés dans la maladie de Wilson. Séminaire maladie de Wilson, Luxembourg.

https://research.dial.uclouvain.be/handle/2078.5/243955

Lanthier, N. (2025). Metabolic steatohepatitis, gut microbiota and skeletal muscle changes: three pieces of the same risky puzzle? From results to new projects. LDRI Seminar, Brussels.

https://research.dial.uclouvain.be/handle/2078.5/259440

Declerck, S., Lanthier, N., & Dahlqvist, G. (2025). La sarcopénie, présente chez les patients cirrhotiques avec une dénutrition modérée à sévère est associée à une densité accrue du tissu adipeux. Revue Médicale de Bruxelles, 46(2), 147. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/259445

Henin, G., Declerck, S., Goffaux, A., André-Dumont, S., Baldin, P., Starkel, P., & Lanthier, N. (2025). Ballooning degeneration and fibrosis are responsible for high liver stiffness in human alcohol-related liver disease. ESBRA, Cliniques universitaires Saint-Luc, Brussels, Belgium.

https://research.dial.uclouvain.be/handle/2078.5/273617

Deswysen, Y., Danse, E., Trefois, P., Van den Eynde, M., & Lanthier, N. (2025). High prevalence of myopenia and myosteatosis in patients with oesophagogastric cancer. Clinical Nutrition ESPEN, 69(October 2025), 829. https://doi.org/10.1016/j.clnesp.2025.07.042 (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/273429

Lanthier, N. (2025). After ESPEN 2025. After ESPEN 2025, ’s Hertogenbosch, Netherlands.

https://research.dial.uclouvain.be/handle/2078.5/273428

Lanthier, N. (2025). Towards comprehensive, general care: the example of steatotic liver disease. Annual Symposium of the Belgian Nutrition Society, Brussels.

https://research.dial.uclouvain.be/handle/2078.5/259439

Henin, G., Goffaux, A., André-Dumont, S., Pendeville, E., Valet, M., Lejeune, T., Dahlqvist, G., Loumaye, A., Starkel, P., & Lanthier, N. (2025). Muscle function is already impaired in non-cirrhotic patients with steatotic liver disease compared to healthy controls. Acta Gastro-Enterologica Belgica, 88(1), A03. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/256541

Lanthier, N. (2025). Gastro-intestinal problems and physical exercise. 37th Belgian Week of Gastroenterology, Le Palais des Congrès, Liège.

https://research.dial.uclouvain.be/handle/2078.5/244566

Terken, C., André-Dumont, S., Henin, G., Orioli, L., Loumaye, A., & Lanthier, N. (2025). Discordance entre la prévalence de la sarcopénie selon les critères diagnostiques chez les patients présentant un diabète de type 2. Revue Médicale de Bruxelles, 46(2), 145. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/272030

Lanthier, N. (2025). Metabolic dysfunction-associated steatotic liver disease: non-invasive tests for diagnosis and prognosis. BASL Wintermeeting 2025, Antwerpen.

https://research.dial.uclouvain.be/handle/2078.5/273612

Deswysen, Y., Danse, E., Trefois, P., Van den Eynde, M., & Lanthier, N. (2025). Oesophagogastric cancers are associated with high rates of myopenia and myosteatosis. Belgian Nutrition Society, Brussels.

https://research.dial.uclouvain.be/handle/2078.5/248960

Lanthier, N. (2025). Lessons to learn from the gut microbiome: a liver disease perspective. In Lanthier, Nicolas (ed.), ESE 2025 Programme Book (p. 82).

https://research.dial.uclouvain.be/handle/2078.5/259435

Lanthier, N. (2025). L’importance du ratio cuivre échangeable/cuivre total (REC) dans le diagnostic de la maladie de Wilson: rationnel et cas cliniques exemplatifs. Séminaire de biologie clinique, Brussels.

https://research.dial.uclouvain.be/handle/2078.5/259441

Lanthier, N. (2025). Les maladies stéatosiques du foie: nouvelle nomenclature, diagnostic et évolution. Congrès d’hépato-gastroentérologie, Bruxelles.

https://research.dial.uclouvain.be/handle/2078.5/243954

André-Dumont, S., Scholtens, J., & Lanthier, N. (2025). Bénéfice du dépistage de l’élasticité hépatique dans la perte de poids des patients atteints d’une maladie hépatique stéatosique métabolique. Revue Médicale de Bruxelles, 46(2), 146. (Original work published 2025)

https://research.dial.uclouvain.be/handle/2078.5/272031

2024

Papier de conférence

Lanthier, N. (2024). Le microbiome intestinal dans la maladie stéatosique métabolique du foie: quels résultats ? quels liens vers les maladies bucco-dentaires ? Colloque de dentisterie de l’Université de Genève, Geneva, Switzerland.

https://research.dial.uclouvain.be/handle/2078.5/31875

Declerck, S., Henin, G., André-Dumont, S., Goffaux, A., Baldin, P., Henry, P., Loumaye, A., Starkel, P., & Lanthier, N. (2024). Nutrition et maladie stéatosique du foie : pas d’évidence d’un impact de la consommation d’aliments ultra-transformés sur la sévérité de l’atteinte hépatique. Livre des résumés, symposium de nutrition clinique 2024, p. 10.

https://research.dial.uclouvain.be/handle/2078.5/272037

Declerck, S., Henin, G., André-Dumont, S., Goffaux, A., Dahlqvist, G., Loumaye, A., Pendeville, E., Lejeune, T., Valet, M., & Lanthier, N. (2024). Frailty in MASLD patients is associated with the presence of diabetes and the degree of liver fibrosis. Acta Gastro-Enterologica Belgica, 87(1), A24. (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/272039

Lanthier, N. (2024). La stéatose hépatique. 18e congrès UCL d’Endocrino-Diabétologie, Brussels, Belgium.

https://research.dial.uclouvain.be/handle/2078.5/31447

Lanthier, N., & Bozadjieva-Kramer, N. (2024). Bile acids in digestive physio(patho)logy. IREC seminar, Brussels.

https://research.dial.uclouvain.be/handle/2078.5/232265

Lanthier, N., & Orioli, L. (2024). Le dépistage de la MASLD en pratique courante en diabétologie: recommandations et nouveautés. Séminaire d’endocrinologie-hépatologie, Bruxelles.

https://research.dial.uclouvain.be/handle/2078.5/243957

Scholtens, J., André-Dumont, S., Henin, G., Dahlqvist, G., & Lanthier, N. (2024). Liver elasticity evolution in metabolic dysfunction-associated steatotic liver disease patients: a real-life prospective study. Acta Gastro-Enterologica Belgica, 87(1), A33. (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/272033

Lanthier, N. (2024). La stéatohépatite métabolique. Journée de la Gastroentérologie (Société Luxembourgeoise de Gastroentérologie), Luxembourg.

https://research.dial.uclouvain.be/handle/2078.5/31876

Declerck, S., Henin, G., Andre-Dumont, S., Goffaux, A., Loumaye, A., Baldin, P., Starkel, P., & Lanthier, N. (2024). Exploring the impact of dietary patterns and ultra-processed food consumption on the severity of biopsy-proven steatotic liver disease. Acta Gastro-Enterologica Belgica, 87(1), A03. (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/241971

Lanthier, N. (2024). MASH et resmetirom. Livre des résumés, Société Royale Belge de Gastro-Entérologie, Actualités, 2024, p. 30-31.

https://research.dial.uclouvain.be/handle/2078.5/243956

Dénos, C., Pachikian, C., Hdidou, S., Dierge, E., Debier, C., Trefois, P., Larondelle, Y., & Lanthier, N. (2024). Creation of snacks enriched with polyunsaturated fatty acids and benefits for metabolic parameters: a double-blind randomised controlled trial in overweight subjects. Acta Gastro-Enterologica Belgica, 87(1), A20. (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/240864

Denos, C., Nain, C. W., Pachikian, B., Hdidou, S., Rasse, C., Dierge, E., Debier, C., Trefois, P., Larondelle, Y., & Lanthier, N. (2024). Création de crackers enrichis en acides gras polyinsaturés avec des bénéfices pour les paramètres métaboliques : un essai contrôlé randomisé en double aveugle chez des sujets en surpoids. Livre des résumés, symposium de nutrition clinique 2024, p. 9.

https://research.dial.uclouvain.be/handle/2078.5/240867

Lanthier, N. (2024). Évaluation biologique des troubles hépatiques : dialogue entre le biologiste et le clinicien pour une prise en charge optimale. Les 24èmes journées marocaines de biologie clinique, Casablanca, Maroc.

https://research.dial.uclouvain.be/handle/2078.5/240413

Lanthier, N., Poujois, A., & Stephenne, X. (2024). La maladie de Wilson: quoi de neuf ? Séminaire Wilson, La Hulpe.

https://research.dial.uclouvain.be/handle/2078.5/238594

Boliaki, N., Henin, G., & Lanthier, N. (2024). Impact of peroxisome proliferator-activated receptor agonists on myosteatosis in the context of metabolic dysfunction-associated steatotic liver disease. Acta Gastro-Enterologica Belgica, 87(1), A01. (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/240859

Article de journal

Borbath, I., Deprez, P., Dewit, O., Lanthier, N., Moreels, T., Starkel, P., & Piessevaux, H. (2024). In Memoriam: René Fiasse (1936-2024). Acta Gastro-Enterologica Belgica, 87(2), 346-347. https://doi.org/10.51821/87.2.13357 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/260873

Zorzi, G., Ngougni Pokem, P., Dahlqvist, G., Delire, B., Lanthier, N., Starkel, P., Horsmans, Y., Aupaix, C., Jnaoui, S., & Gruson, D. (2024). Evaluation of a Ten-Antigen Immunodot Test in Autoimmune Hepatitis and Primary Biliary Cholangitis: Lessons Learned for a Tertiary Care Academic Hospital. Diagnostics, 14(17), 1882 [1-13]. https://doi.org/10.3390/diagnostics14171882 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/273267

Boliaki, N., Henin, G., Bale, G. L., & Lanthier, N. (2024). Impact of Peroxisome Proliferator-Activated Receptor Agonists on Myosteatosis in the Context of Metabolic Dysfunction-Associated Steatotic Liver Disease. Discovery medicine, 36(185), 1139-1153. https://doi.org/10.24976/discov.med.202436185.104 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/273272

Bale, G. L., Clarembeau, F., Starkel, P., Dahlqvist, G., Horsmans, Y., & Lanthier, N. (2024). Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis. Clinics and Research in Hepatology and Gastroenterology, 48(8), 102428 [1-7]. https://doi.org/10.1016/j.clinre.2024.102428 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/247432

Bozadjieva-Kramer, N., Shin, J. H., Li, Z., Rupp, A. C., Miller, N., Kernodle, S., Lanthier, N., Henry, P., Seshadri, N., Myronovych, A., MacDougald, O. A., O’Rourke, R. W., Kohli, R., Burant, C. F., Rothberg, A. E., & Seeley, R. J. (2024). Intestinal FGF15 regulates bile acid and cholesterol metabolism but not glucose and energy balance. JCI Insight, 9(7), e174164 [1-21]. https://doi.org/10.1172/jci.insight.174164 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/213603

Henin, G., & Lanthier, N. (2024). What references and what gold standard should be used to assess myosteatosis in chronic liver disease ? Journal of Hepatology, 81(6), e273-e274. https://doi.org/10.1016/j.jhep.2024.07.003 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/241941

Henin, G., Loumaye, A., Leclercq, I., & Lanthier, N. (2024). Myosteatosis: diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver disease. JHEP Reports, 6(2), 100963 [1-21]. https://doi.org/10.1016/j.jhepr.2023.100963 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/31538

Dahlqvist, G., Dewit, O., Lanthier, N., & Starkel, P. (2024). Transplantation, MICI et stéatose hépatique : quelques nouveautés en 2023. Louvain médical, 143(02-03), 183-188. (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/240432

Harrison, S. A., Bedossa, P., Guy, C. D., Schattenberg, J. M., Loomba, R., Taub, R., Labriola, D., Moussa, S. E., Neff, G. W., Rinella, M. E., Anstee, Q. M., Abdelmalek, M. F., Younossi, Z., Baum, S. J., Francque, S., Charlton, M. R., Newsome, P. N., Lanthier, N., Schiefke, I., et al. (2024). A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine, 390(6), 497-509. https://doi.org/10.1056/nejmoa2309000 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/31873

De Ledinghen, V., Furuhashi, M., Giannini, C., Chai, J., Xia, Z.-F., Jun, D. W., Li, G.-J., Treeprasertsuk, S., Li, Y.-X., Cheung, T. T., Zhang, F., Goh, G. B.-B., Seto, W.-K., Fouad, Y., Huang, H., Di Sessa, A., Li, Q.-H., Cholongitas, E., Zhang, L., et al. (2024). A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease. Hepatology International, 18(4), 1178-1201. https://doi.org/10.1007/s12072-024-10702-5 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/238937

Fortunati, F., Froidure, A., Baldin, P., Horsmans, Y., Lanthier, N., Dahlqvist, G., & Delire, B. (2024). Pirfenidone-induced liver injury, a case report of a rare idiosyncratic reaction. Therapeutic Advances in Drug Safety, 15, 1-10. https://doi.org/10.1177/20420986241270866 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/248731

Lanthier, N. (2024). Stéatose hépatique : ce que l’endocrinologue doit savoir. Louvain médical, 143(04), 281-283. (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/215629

Henin, G., Baldin, P., Frans, C., Havelange, V., Delire, B., Yombi, J. C., & Lanthier, N. (2024). Metabolic dysfunction-associated steatotic liver disease : the tree that hides the forest? Acta Gastro-Enterologica Belgica, 87(2), 344-345. https://doi.org/10.51821/87.2.13087 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/260874

Henin, G., Loumaye, A., Deldicque, L., Leclercq, I., & Lanthier, N. (2024). Unlocking liver health: Can tackling myosteatosis spark remission in metabolic dysfunction-associated steatotic liver disease? Liver International, 44(8), 1781-1796. https://doi.org/10.1111/liv.15938 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/232266

Haxhe, S., Baldin, P., Trefois, P., Havelange, V., & Lanthier, N. (2024). Jaundice with severe leucocytosis. Journal of Hepatology, 80(3), e103-e105. https://doi.org/10.1016/j.jhep.2023.10.014 (Original work published 2024)

https://research.dial.uclouvain.be/handle/2078.5/242080

2023

Article de journal

Lanthier, N. (2023). La sarcopénie dans la cirrhose. Medi-Sphère, 739(Gastro News n°4), 12-17. (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/31591

Lanthier, N. (2023). Sarcopenie bij cirrose. Ortho-Rheumato, 21(6), 28-32. (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/31578

Lanthier, N. (2023). Sarcopenie bij cirrose. Medi-Sfeer, 739(Gastro News n°4), 12-17. (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/31592

Dumont, C., Lanthier, N., & Dahlqvist, G. (2023). Fibrosis and steatosis of the liver graft: are non-invasive tests useful? A short review. Clinics and Research in Hepatology and Gastroenterology, 47(8), 102194 [1-7]. https://doi.org/10.1016/j.clinre.2023.102194 (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/238531

Dahlqvist, G., Delire, B., Dewit, O., Lanthier, N., & Piessevaux, H. (2023). Innovations 2022 en hépato-gastroentérologie. Louvain médical, 142(2), 93-100. (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/100288

Dolly, A., Pötgens, S., Thibaut, M., Neyrinck, A., de Castro, G. S., Galbert, C., Lefevre, C., Wyart, E., Gomes, S. P., Gonçalves, D. C., Lanthier, N., Baldin, P., Huot, J. R., Bonetto, A., Seelaender, M., Delzenne, N., Sokol, H., & Bindels, L. (2023). Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle, 14(3), 1569-1582. https://doi.org/10.1002/jcsm.13246 (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/239047

Bourseau, S., Bozadjieva-Kramer, N., Goffaux, A., Baldin, P., Etogo-Asse, F., Trefois, P., & Lanthier, N. (2023). Are elevated systemic bile acids involved in the pathophysiology of sarcopenia and liver injury following gastric bypass? Acta Gastro-Enterologica Belgica, 86(2), 377-381. https://doi.org/10.51821/86.2.11517 (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/231946

Lanthier, N., & Armstrong, M. J. (2023). Metabolic steatosis: recent scientific data also support a change in nomenclature. Acta Gastro-Enterologica Belgica, 86(1), 105-106. https://doi.org/10.51821/86.1.11385 (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/240471

Binet, Q., Loumaye, A., Hermans, M., & Lanthier, N. (2023). A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes Patients. Journal of clinical and translational hepatology, 11(6), 1377-1386. https://doi.org/10.14218/jcth.2023.00117 (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/217345

Binet, Q., Hermans, M., & Lanthier, N. (2023). Screening for NAFLD and its severity in type 2 diabetic patients: value of magnetic resonance imaging and outstanding issues. Journal of Hepatology, 78(5), e166-e167. https://doi.org/10.1016/j.jhep.2022.12.004 (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/217343

Lanthier, N., Lefere, S., De Schepper, H., & Reenaers, C. (2023). Clinical nutrition, skeletal muscle and liver disease: linking the dots for good management. Acta Gastro-Enterologica Belgica, 86(2), 267-268. https://doi.org/10.51821/86.1.12052 (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/234220

Lanthier, N. (2023). La sarcopénie dans la cirrhose. Ortho-Rhumato, 21(6), 28-32. (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/31577

Cardinale, V., Lanthier, N., Baptista, P. M., Carpino, G., Carnevale, G., Orlando, G., Angelico, R., Manzia, T. M., Schuppan, D., Pinzani, M., Alvaro, D., Ciccocioppo, R., & Uygun, B. E. (2023). Cell transplantation-based regenerative medicine in liver diseases. Stem cell reports, 18(8), 1555-1572. https://doi.org/10.1016/j.stemcr.2023.06.005 (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/232474

Declerck, S., Henin, G., & Lanthier, N. (2023). Alcohol Consumption and Skeletal Muscle: What We Know and What We Would Like to Know. Calcified Tissue International, 113(3), 354-356. https://doi.org/10.1007/s00223-023-01113-z (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/241969

Papier de conférence

Sansen, P.-Y., Hainaut, P., Baldin, P., Secco, L.-P., Vanlier, C., & Lanthier, N. (2023). Jaundice, fever and rash: when skin and liver histology give the diagnosis... BASL Winter meeting 2023, Mons.

https://research.dial.uclouvain.be/handle/2078.5/249110

Binet, Q., Loumaye, A., Hermans, M., & Lanthier, N. (2023). Benefits of systematic use of non-invasive fibrosis scores rather than fatty liver index in type 2 diabetes patients: a prospective study. Acta Gastro-Enterologica Belgica, 86(1), A20. (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/233623

Raevens, S., Weichselbaum, L., Lanthier, N., & Nevens, F. (2023). Digital Post-AASLD 2022 educational Meeting. Digital post-AASLD meeting 2022, Online.

https://research.dial.uclouvain.be/handle/2078.5/102618

Lanthier, N. (2023). La sarcopénie en cas de cirrhose: évaluation, impact et prise en charge. Livre des résumés. Published. Actualités en gastro-entérologie (Société Royale Belge de Gastro-Entérologie), Namur.

https://research.dial.uclouvain.be/handle/2078.5/31581

Lanthier, N. (2023). Patholgie métabolique (insulinorésistance): la stéatohépatite métabolique. La revue Maghrébine d’Endocrinologie-Diabète et de Reproduction, 27(1), 22. (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/105556

Delorme, A., Goffaux, A., De Azevedo Coutinho Pereira, D., Dumont, C., Philippart, M., Henin, G., Braem, F., Dubois, E., Ciccarelli, O., Trefois, P., Lanthier, N., & Dahlqvist, G. (2023). Myosteatosis in the liver transplant candidate: Is it the future prognostic marker ? Acta Gastro-Enterologica Belgica, 86(1), A11. (Original work published 2023)

https://research.dial.uclouvain.be/handle/2078.5/106339

Henin, G., Baldin, P., Havelange, V., Delire, B., Yombi, J. C., & Lanthier, N. (2023). Metabolic dysfunction-associated steatotic liver disease : the tree that hides the forest ? BASL Winter meeting 2023, Mons.

https://research.dial.uclouvain.be/handle/2078.5/31580

2022

Article de journal

Ventura-Cots, M., Argemi, J., Jones, P. D., Lackner, C., El Hag, M., Abraldes, J. G., Alvarado, E., Clemente, A., Ravi, S., Alves, A., Alboraie, M., Altamirano, J., Barace, S., Bosques, F., Brown, R., Caballeria, J., Cabezas, J., Carvalhana, S., Cortez-Pinto, H., et al. (2022). Clinical, histological and molecular profiling of different stages of alcohol-related liver disease. Gut, 71(9), 1856-1866. https://doi.org/10.1136/gutjnl-2021-324295 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/166845

Pichon, C., Nachit, M., Gillard, J., Vande Velde, G., Lanthier, N., & Leclercq, I. (2022). Impact of L-ornithine L-aspartate on non-alcoholic steatohepatitis-associated hyperammonemia and muscle alterations. Frontiers in Nutrition, 9, 1051157 [1-15]. https://doi.org/10.3389/fnut.2022.1051157 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/31584

Dumont, C., Wuestenberghs, F., Lanthier, N., Piessevaux, H., & Dahlqvist, G. (2022). Malnutrition is highly prevalent in hospitalized cirrhotic patients and associates with a poor outcome. Acta Gastro-Enterologica Belgica, 85(2), 311-319. https://doi.org/10.51821/85.2.9016 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/165900

Etienne, Q., Lebrun, V., Komuta, M., Navez, B., Thissen, J.-P., Leclercq, I., & Lanthier, N. (2022). Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis. Metabolites, 12(7), 625 [1-16]. https://doi.org/10.3390/metabo12070625 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/217351

Lanthier, N., Delire, B., Dahlqvist, G., Denis, M. A., & Moreels, T. (2022). Innovations 2021 en hépato-gastro-entérologie. Louvain médical, 141(2), 78-84. (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/164785

Goffaux, A., Delorme, A., Dahlqvist, G., & Lanthier, N. (2022). Improving the prognosis before and after liver transplantation: Is muscle a game changer? World Journal of Gastroenterology, 28(40), 5807-5817. https://doi.org/10.3748/wjg.v28.i40.5807 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/164355

Lanthier, N., & Vanuytsel, T. (2022). From the editor’s desk... Acta Gastro-Enterologica Belgica, 83(1), 3-4. (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/165306

Vande Berg, P., Ulaj, A., de Broqueville, G., de Vos, M., Delire, B., Hainaut, P., Thissen, J.-P., Starkel, P., Komuta, M., Henry, P., & Lanthier, N. (2022). Liver Decompensation after Bariatric Surgery in the Absence of Cirrhosis. Obesity Surgery : including Laparoscopy and Allied Care, 32(4), 1227-1235. https://doi.org/10.1007/s11695-022-05930-3 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/214684

Lanthier, N., Lebrun, V., Molendi-Coste, O., van Rooijen, N., & Leclercq, I. (2022). Liver Fetuin-A at Initiation of Insulin Resistance. Metabolites, 12(11), 1023 [1-10]. https://doi.org/10.3390/metabo12111023 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/217352

Lanthier, N., Delire, B., Dahlqvist, G., Denis, M. A., & Moreels, T. (2022). Hépatologie, endoscopie et proctologie: quelques faits marquants en 2021. Louvain médical, 141(2), 78-84. (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/166173

Rodriguez, J., Neyrinck, A., Van Kerckhoven, M., Gianfrancesco, M. A., Renguet, E., Bertrand, L., Cani, P., Lanthier, N., Cnop, M., Paquot, N., Thissen, J.-P., Bindels, L., & Delzenne, N. (2022). Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individuals. BMC Medicine, 20(1), 110 [1-20]. https://doi.org/10.1186/s12916-022-02299-z (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/165988

Binet, Q., Loumaye, A., Preumont, V., Thissen, J.-P., Hermans, M., & Lanthier, N. (2022). Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ? Acta Gastro-Enterologica Belgica, 85(2), 346-357. https://doi.org/10.51821/85.2.9775 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/165451

Clerbaux, L.-A., Mayasich, S. A., Muñoz, A., Soares, H., Petrillo, M., Albertini, M. C., Lanthier, N., Grenga, L., & Amorim, M.-J. (2022). Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. Journal of Clinical Medicine, 11(19), 5691 [1-23]. https://doi.org/10.3390/jcm11195691 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/274827

Henin, G., Lanthier, N., & Dahlqvist, G. (2022). Pathophysiological changes of the liver-muscle axis in end-stage liver disease: what is the right target? Acta Gastro-Enterologica Belgica, 85(4), 611-624. https://doi.org/10.51821/85.4.10899 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/164620

Méndez-Sánchez, N., Bugianesi, E., Gish, R. G., Lammert, F., Tilg, H., Nguyen, M. H., Sarin, S. K., Fabrellas, N., Zelber-Sagi, S., Fan, J.-G., Shiha, G., Targher, G., Zheng, M.-H., Chan, W.-K., Vinker, S., Kawaguchi, T., Castera, L., Yilmaz, Y., Korenjak, M., et al. (2022). Global multi-stakeholder endorsement of the MAFLD definition. The lancet. Gastroenterology & hepatology, 7(5), 388-390. https://doi.org/10.1016/S2468-1253(22)00062-0 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/165923

André-Dumont, S., & Lanthier, N. (2022). Quelle alimentation proposer aux patients présentant une stéatohépatite non-alcoolique ? Nutrition Clinique et Métabolisme, 36(1), 12-20. https://doi.org/10.1016/j.nupar.2021.11.001 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/272036

Lanthier, N., & Spahr, L. (2022). Letter: the value of quality liver biopsy before initiation of corticosteroids for severe alcoholic hepatitis. Alimentary Pharmacology and Therapeutics, 55(7), 889-890. https://doi.org/10.1111/apt.16835 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/166021

Lanthier, N., & Delzenne, N. (2022). Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time? Cells, 11(17), 2718 [1-17]. https://doi.org/10.3390/cells11172718 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/164896

Lanthier, N., Ruiz Moreno, A., Dahlqvist, G., Delire, B., Starkel, P., & Horsmans, Y. (2022). Results of a screening campaign for hepatitis C viral infection in a Brussels hospital : do we need to go further? Acta Gastro-Enterologica Belgica, 82(2), 338. (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/214501

Binet, Q., Annet, L., Danse, E., Goffette, P., & Lanthier, N. (2022). Hepatobiliary and Pancreatic: An uncommon cause of portal hypertension. Journal of gastroenterology and hepatology, 37(10), 1843. https://doi.org/10.1111/jgh.15961 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/164936

Maccioni, L., Loriot, A., Dewulf, J., Bommer, G., Horsmans, Y., Lanthier, N., Leclercq, I., Schnabl, B., & Starkel, P. (2022). Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans. Alimentary Pharmacology and Therapeutics, 56(6), 1055-1070. https://doi.org/10.1111/apt.17177 (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/215466

Papier de conférence

Lanthier, N., Degroote, H., & Vanwolleghem, T. (2022). Digital post-EASL educational meeting 2022. Digital post-EASL educational meeting 2022, Online.

https://research.dial.uclouvain.be/handle/2078.5/164860

Lanthier, N. (2022). Alcool, stéatose et microbiote. Livre des résumés. Published. Société Royale Belge de Gastroentérologie (SRBGE), Namur.

https://research.dial.uclouvain.be/handle/2078.5/107880

Dumont, C., Iesari, S., Lanthier, N., Henin, G., Bonaccorsi Riani, E., Ciccarelli, O., Coubeau, L., Baldin, P., Aydin, S., & Dahlqvist, G. (2022). Assessment of a transient elastography in predicting the graft fibrosis after liver transplantation and validation of the Venturi score in an adult population. Acta Gastro-Enterologica Belgica, 85(1), A20. (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/164867

Lanthier, N. (2022). Microbiote intestinal et foie. Journée de formation continue de l’ASMA (Association Scientifique de Médecine d’Assurance), Bruxelles.

https://research.dial.uclouvain.be/handle/2078.5/164549

Lanthier, N. (2022). Malnutrition and liver disease: assessement and implementation of nutritional therapy. Belgian Association for the Study of the Liver (BASL) Winter Meeting & Liver Course, Wallonia Conference Center Mons (WCCM).

https://research.dial.uclouvain.be/handle/2078.5/99940

Lanthier, N. (2022). Cibler le microbiome intestinal pour traiter la maladie stéatosique du foie liée à une dysfonction métabolique (MAFLD): preuves et résultats. NutriFacts, Oct-Nov-Dec(4), 20-24. (Original work published 2022)

https://research.dial.uclouvain.be/handle/2078.5/165160

Lanthier, N. (2022). Why should the clinician be interested in sekeletal muscle? IREC seminar, Brussels.

https://research.dial.uclouvain.be/handle/2078.5/164417

2021

Papier de conférence

Lanthier, N., Vande Berg, P., Vande Berg, A., Harkemanne, E., Peeters, C., & Havelange, V. (2021). How skin and liver can lead to diagnosis. Belgian Association for the Study of the Liver (BASL) liver meeting, Mons.

https://research.dial.uclouvain.be/handle/2078.5/167142

Lanthier, N. (2021). The role of gut microbiota. EASL NAFLD summit 2021, Digital.

https://research.dial.uclouvain.be/handle/2078.5/167132

Salavrakos, M., de Timary, P., Ruiz Moreno, A., Thissen, J.-P., & Lanthier, N. (2021). The importance of personalised care in metabolic dysfunction-associated fatty liver disease. Belgian Association for the Study of the Liver (BASL) liver meeting, Mons.

https://research.dial.uclouvain.be/handle/2078.5/167138

Lanthier, N. (2021). La stéatohépatite non-alcoolique (NASH): définition, diagnostic et prise en charge thérapeutique. Innovation contre le syndrome métabolique, Charleroi.

https://research.dial.uclouvain.be/handle/2078.5/165576

Lanthier, N. (2021). The gut microbiota in metabolic dysfunction-associated fatty liver disease. Conference book. Published. Liver-gut axis worshop, Falk symposium, German Association for the Study of the Liver (GASL), Münster.

https://research.dial.uclouvain.be/handle/2078.5/166648

Lanthier, N. (2021). La stéatohépatite non-alcoolique. Société de Médecine de Charleroi, Charleroi.

https://research.dial.uclouvain.be/handle/2078.5/167167

Vande Berg, P., Ulaj, A., de Broqueville, G., de Vos, M., Delire, B., Hainaut, P., Thissen, J.-P., Starkel, P., Henry, P., Komuta, M., & Lanthier, N. (2021). Acute liver decompensation following bariatric surgery in patients without cirrhosis: clinical presentation, histological findings and management. Acta Gastro-Enterologica Belgica, 84(1), A09. (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167258

Article de journal

Francque, S. M., Bedossa, P., Ratziu, V., Anstee, Q. M., Bugianesi, E., Sanyal, A. J., Loomba, R., Harrison, S. A., Balabanska, R., Mateva, L., Lanthier, N., Alkhouri, N., Moreno, C., Schattenberg, J. M., Stefanova-Petrova, D., Vonghia, L., Rouzier, R., Guillaume, M., Hodge, A., et al. (2021). A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. New England Journal of Medicine, 385(17), 1547-1558. https://doi.org/10.1056/nejmoa2036205 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/166526

Lanthier, N., Rodriguez, J., Nachit, M., Hiel, S., Trefois, P., Neyrinck, A., Cani, P., Bindels, L., Thissen, J.-P., & Delzenne, N. (2021). Publisher Correction: Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. Scientific Reports, 11(1), 6123. https://doi.org/10.1038/s41598-021-85083-y (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/164767

Baldin, P., Van den Eynde, M., Mlecnik, B., Bindea, G., Beniuga, G., Carrasco, J., Haicheur, N., Marliot, F., Lafontaine, L., Fredriksen, T., Lanthier, N., Hubert, C., Navez, B., Huyghe, N., Pagès, F., Mourin, A., Galon, J., & Komuta, M. (2021). Prognostic assessment of resected colorectal liver metastases integrating pathological features, RAS mutation and Immunoscore. Journal of Pathology: Clinical Research, 7(1), 27-41. https://doi.org/10.1002/cjp2.178 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/168619

Lanthier, N., Starkel, P., & Dahlqvist, G. (2021). Muscle mass depletion in chronic liver diseases: An accelerated model of aging or a distinct entity? Clinics and Research in Hepatology and Gastroenterology, 45(4), 101721 [1-2]. https://doi.org/10.1016/j.clinre.2021.101721 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/166197

Lanthier, N. (2021). Le lanifibranor, un activateur des trois isoformes de PPAR, entraîne une régression de l’inflammation et de la fibrose hépatique dans la NASH ainsi que des effets métaboliques bénéfiques. Louvain médical, 140(02), 110. (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/165927

Spahr, L., Lanthier, N., Tihy, M., Frossard, J.-L., Rubbia-Brandt, L., & Goossens, N. (2021). Clinical presentation and gene expression of acute alcohol-induced microvesicular steatosis mimicking alcoholic hepatitis. Hepatology Communications, 5(4), 618-628. https://doi.org/10.1002/hep4.1669 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167561

Lanthier, N., Borbath, I., Dahlqvist, G., Delire, B., & Dewit, O. (2021). Stéatose métabolique, carcinome hépatocellulaire, prurit cholestatique, encéphalopathie et maladies inflammatoires intestinales: quelles nouveautés en 2020? Louvain médical, 140(2), 108-115. (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167119

Vande Berg, P., Vande Berg, A., Harkemanne, E., Peeters, C., Havelange, V., & Lanthier, N. (2021). How skin and liver can lead to diagnosis. Acta Gastro-Enterologica Belgica, 84(4), 682-683. https://doi.org/10.51821/84.4.024 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/166782

Vande Berg, P., Borbath, I., Baldin, P., Vande Berg, D., Hainaut, P., & Lanthier, N. (2021). Granuloma formation within perihepatic lymphadenopathy. Clinics and Research in Hepatology and Gastroenterology, 45(6), 101504 [1-4]. https://doi.org/10.1016/j.clinre.2020.07.009 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/168020

Lanthier, N. (2021). La maladie stéatosique du foie liée à une dysfonction métabolique : enfin une nomenclature plus claire avec des critères diagnostiques positifs. Louvain médical, 140(02), 109. (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/165931

Lanthier, N., Rodriguez, J., Nachit, M., Hiel, S., Trefois, P., Neyrinck, A., Cani, P., Bindels, L., Thissen, J.-P., & Delzenne, N. (2021). Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients. Scientific Reports, 11(1), 659 [1-14]. https://doi.org/10.1038/s41598-020-79718-9 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167816

Leyrolle, Q., Cserjesi, R., Mulders, M. D. G. H., Zamariola, G., Hiel, S., Gianfrancesco, M. A., Rodriguez, J., Portheault, D., Amadieu, C., Leclercq, S., Bindels, L., Neyrinck, A., Cani, P., Karkkainen, O., Haninheva, K., Lanthier, N., Trefois, P., Paquot, N., Cnop, M., et al. (2021). Specific gut microbial, biological, and psychiatric profiling related to binge eating disorders: A cross-sectional study in obese patients. Clinical Nutrition, 40, 2035-2044. https://doi.org/10.1016/j.clnu.2020.09.025 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167610

Lanthier, N., Mahiat, C., Henrard, S., Starkel, P., Gilard, I., De Brauwer, I., Cornette, P., & Boland, B. (2021). Gastro-intestinal symptoms are associated with a lower in-hospital mortality rate in frail older patients hospitalized for COVID-19. Acta Gastro-Enterologica Belgica, 84(1), 135-136. https://doi.org/10.51821/84.1.824 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/216137

Hamoir, C., Horsmans, Y., Starkel, P., Dahlqvist, G., Negrin Dastis, S., & Lanthier, N. (2021). Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents. Acta Gastro-Enterologica Belgica, 84(1), 25-32. https://doi.org/10.51821/84.1.420 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167563

Lanthier, N., Starkel, P., & Dahlqvist, G. (2021). Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible? Clinics and Research in Hepatology and Gastroenterology, 45(2), 101661 [1-3]. https://doi.org/10.1016/j.clinre.2021.101661 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167214

Vanuytsel, T., & Lanthier, N. (2021). The growing impact of Acta Gastro-Enterologica Belgica. Acta Gastro-Enterologica Belgica, 84(1), 1-2. (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167270

Salavrakos, M., de Timary, P., Moreno, A., Thissen, J.-P., & Lanthier, N. (2021). Fructoholism in adults: the importance of personalised care in metabolic dysfunction-associated fatty liver disease. JHEP Reports, 4(1), 100396 [1-2]. https://doi.org/10.1016/j.jhepr.2021.100396 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/165890

Nachit, M., Lanthier, N., Rodriguez, J., Neyrinck, A., Cani, P., Bindels, L., Hiel, S., Pachikian, B. D., Trefois, P., Thissen, J.-P., & Delzenne, N. (2021). A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients. JHEP Reports, 3(4), 100323 [1-10]. https://doi.org/10.1016/j.jhepr.2021.100323 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/165910

Knudsen, C., Neyrinck, A., Leyrolle, Q., Baldin, P., Leclercq, S., Rodriguez, J., Beaumont, M., Cani, P., Bindels, L., Lanthier, N., & Delzenne, N. (2021). Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice. The Journal of Nutrition, 151(6), 1507-1516. https://doi.org/10.1093/jn/nxab032 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167014

Leyrolle, Q., Cserjesi, R., D.G.H. Mulders, M., Zamariola, G., Hiel, S., Gianfrancesco, M. A., Portheault, D., Amadieu, C., Bindels, L., Leclercq, S., Rodriguez, J., Neyrinck, A., Cani, P., Lanthier, N., Trefois, P., Bindelle, J., Paquot, N., Cnop, M., Thissen, J.-P., et al. (2021). Prebiotic effect on mood in obese patients is determined by the initial gut microbiota composition: a randomized, controlled trial. Brain, Behavior, and Immunity, 94(May), 289-298. https://doi.org/10.1016/j.bbi.2021.01.014 (Original work published 2021)

https://research.dial.uclouvain.be/handle/2078.5/167474

2020

Papier de conférence

Lanthier, N., Rodriguez, J., Nachit, M., Hiel, S., Trefois, P., Bindels, L., Neyrinck, A., Cani, P., Thissen, J.-P., & Delzenne, N. (2020). New determinants of liver steatosis and fibrosis in obese patients: results of a prospective clinical study. Clinical Nutrition ESPEN, 40, 438-439. https://doi.org/10.1016/j.clnesp.2020.09.104 (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168612

Francque, S., Bedossa, P., Ratziu, V., Anstee, Q., Bugianesi, E., Sanyal, A., Loomba, R., Harrison, S. A., Balabanska, R. I., Mateva, L., Lanthier, N., & et al. (2020). The PanPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the NATIVE Phase 2b trial. Hepatology, 72(1), 9A-11A. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168032

Lamotte, A., Leclercq, I., & Lanthier, N. (2020). The mechanisms of steatosis pathogenesis during NASH development. Acta Gastro-Enterologica Belgica, 83(1). (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/169804

Lanthier, N. (2020). General medical management of variceal bleeding and endoscopic definitions of portal hypertension related lesions. BSGIE annual meeting 2020, Brussels.

https://research.dial.uclouvain.be/handle/2078.5/168569

Article de journal

Hiel, S., Gianfrancesco, M. A., Rodriguez, J., Portheault, D., Leyrolle, Q., Bindels, L., Gomes da Silveira Cauduro, C., Mulders, M. D. G. H., Zamariola, G., Azzi, A.-S., Kalala, G., Pachikian, B. D., Amadieu, C., Neyrinck, A., Loumaye, A., Cani, P., Lanthier, N., Trefois, P., Klein, O., et al. (2020). Link between gut microbiota and health outcomes in inulin -treated obese patients: Lessons from the Food4Gut multicenter randomized placebo-controlled trial. Clinical Nutrition, 39(12), 3618-3628. https://doi.org/10.1016/j.clnu.2020.04.005 (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168381

Lanthier, N., & Vanuytsel, T. (2020). The changing landscape of hepatology and gastroenterology. Acta Gastro-Enterologica Belgica, 83(3), 371-372. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168014

Lanthier, N., & Tim Vanuytsel. (2020). For better visibility of Acta Gastro-Enterologica Belgica. Acta Gastro-Enterologica Belgica, 83(2), 243-244. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/165307

Dahlqvist, G., Delire, B., Dewit, O., Coubeau, L., Horsmans, Y., Lanthier, N., & Moreels, T. (2020). 2019 innovations in hepato-gastroenterology and hepatic transplantation surgery. Louvain médical, 139(02), 106-113. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168624

Rodriguez, J., Hiel, S., Neyrinck, A., Le Roy, T., Pötgens, S., Leyrolle, Q., Pachikian, B. D., Gianfrancesco, M. A., Cani, P., Paquot, N., Cnop, M., Lanthier, N., Thissen, J.-P., Bindels, L., & Delzenne, N. (2020). Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients. Gut, 69(11), 1975-1987. https://doi.org/10.1136/gutjnl-2019-319726 (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/169434

Lanthier, N., & Vanuytsel, T. (2020). Metabolic dysfunction-associated fatty liver disease: a new clearer nomenclature with positive diagnostic criteria. Acta Gastro-Enterologica Belgica, 83(4), 513-515. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168023

Lanthier, N. (2020). Physiopathologie de la NASH : de nouveaux facteurs de risque identifiés ? Louvain médical, 139(7), 405-410. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168845

Delire, B., Komuta, M., Michaux, L., & Lanthier, N. (2020). A rare cause of high liver stiffness. Acta Gastro-Enterologica Belgica, 83(4), 675-676. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168025

Mahiat, C., Henrard, S., Gilard, I., Lanthier, N., Starkel, P., De Brauwer, I., Cornette, P., & Boland, B. (2020). COVID-19 : présentation clinique et mortalité des 50 premiers patients gériatriques hospitalisés aux Cliniques universitaires Saint-Luc au printemps 2020. Louvain médical, 139 (09-10), 503-511. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/216142

Lanthier, N., & Horsmans, Y. (2020). L’acide obéticholique comme traitement pharmacologique pour les patients atteints de stéatohépatite non-alcoolique fibrosante: des résultats intermédiaires prometteurs. Louvain médical, 139(02), 107. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/168614

Lanthier, N., & Francque, S. (2020). NASH : a welfare disease with emerging questions and adequate answer attempts. Acta Gastro-Enterologica Belgica, 83(2), 339. (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/167210

Lanthier, N. (2020). Les nouveaux traitements de la stéatohépatite non-alcoolique. Nutrition Clinique et Métabolisme, 34(3), 216-222. https://doi.org/10.1016/j.nupar.2020.04.003 (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/166591

Clarembeau, F., Bale, G. L., & Lanthier, N. (2020). Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments. Clinical science (London, England : 1979), 134(16), 2117-2135. https://doi.org/10.1042/CS20200022 (Original work published 2020)

https://research.dial.uclouvain.be/handle/2078.5/217700

2019

Article de journal

Lanthier, N., & Spahr, L. (2019). Resident liver progenitor cells: Proofs of their contribution to human liver regeneration. Clinics and Research in Hepatology and Gastroenterology, 43(6), 646-648. https://doi.org/10.1016/j.clinre.2019.02.006 (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/170698

Ulpiano Trillig, A., Ramoisiaux, L., Komuta, M., & Lanthier, N. (2019). Autoimmune hepatitis in a patient with thymectomy: the benefit of histology and MUM-1 immunostaining. Acta Gastro-Enterologica Belgica, 82(4), 550-551. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/169944

Starkel, P., Schnabl, B., Leclercq, S., Komuta, M., Bataller, R., Argemi, J., Palma, E., Chokshi, S., Hellerbrand, C., Maccioni, L., Lanthier, N., & Leclercq, I. (2019). Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis. Hepatology Communications, 3(7), 867-882. https://doi.org/10.1002/hep4.1364 (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/168231

Salavrakos, M., Piessevaux, H., Komuta, M., Lanthier, N., & Starkel, P. (2019). Fibroscan Reliably Rules Out Advanced Liver Fibrosis and Significant Portal Hypertension in Alcoholic Patients. Journal of Clinical Gastroenterology, 53(10), 772-778. https://doi.org/10.1097/MCG.0000000000001119 (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/168183

Muyldermans, G., Bielen, R., Botterman, R., Bourgeois, S., Colle, I., Deressa, B., Devolder, G., Horsmans, Y., Hutse, V., Lanthier, N., Lasser, L., Platteau, S., Robaeys, G., Suin, V., Verhelst, X., Van Vlierberghe, H., & Van Baelen, L. (2019). Hepatitis C virus (HCV) prevalence estimation in the adult general population in Belgium : a meta-analysis. Acta Gastro-Enterologica Belgica, 82(4), 479-485. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/169943

Moreels, T., Fiasse, R., & Lanthier, N. (2019). The history of Acta Gastro-Enterologica Belgica. Acta Gastro-Enterologica Belgica, 82(1), 57-61. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/170282

Knudsen, C., Neyrinck, A., Lanthier, N., & Delzenne, N. (2019). Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions? Current Opinion in Clinical Nutrition and Metabolic Care, 22(5), 393-400. https://doi.org/10.1097/MCO.0000000000000584 (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/170178

Clarembeau, F., Komuta, M., Horsmans, Y., & Lanthier, N. (2019). Impact of liver inflammation on whole body insulin resistance : a case report on primary biliary cholangitis. Acta Gastro-Enterologica Belgica, 82(4), 536-538. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/217697

Mahfouz, E., & Lanthier, N. (2019). Acute pancreatitis and obesity: where is the problem? Acta Gastro-Enterologica Belgica, 82(1), 104. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/170283

Lanthier, N., Ruiz-Moreno, A., Dahlqvist, G., Delire, B., Starkel, P., & Horsmans, Y. (2019). Results of a screening campaign for hepatitis C viral infection in a Brussels hospital : do we need to go further? Acta Gastro-Enterologica Belgica, 82(2), 338. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/170285

Lanthier, N., & Moreels, T. (2019). The future of Acta Gastro-Enterologica Belgica. Acta Gastro-Enterologica Belgica, 82(1), 3-4. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/170280

Papier de conférence

Lanthier, N. (2019). NASH: quelles armes face à l’épidémie? Journée du Président, Société Royale Belge de Gastro-Entérologie (SRBGE), Namur.

https://research.dial.uclouvain.be/handle/2078.5/233871

Lanthier, N. (2019). Percutaneous gastrostomy and jejunostomy: indications, techniques and follow-up. Belgian Week of Gastroenterology (BWGE) Postgraduate course, Antwerpen.

https://research.dial.uclouvain.be/handle/2078.5/167049

Lejeune, A., Starkel, P., Louvet, A., Hittelet, A., Bazille, C., Bastens, B., Orlent, H., Lasser, L., Dekoninck, X., Negrin Dastis, S., Delwaide, J., Geerts, A., de Galocsy, C., Putzeys, V., Langlet, P., Reynaert, H., Francque, S., Komuta, M., & Lanthier, N. (2019). New concepts in liver regeneration mechanisms in human severe alcoholic steatohepatitis. Acta Gastro-Enterologica Belgica, 82(1), A12. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/240422

Spahr, L., Lanthier, N., Rubbia-Brandt, L., & Goossens, N. (2019). Clinical presentation and transcriptome analysis of acute alcohol-induced microvesicular steatosis mimicking alcoholic steatohepatitis. Hepatology, 70(1), 174A. (Original work published 2019)

https://research.dial.uclouvain.be/handle/2078.5/170273

Lanthier, N. (2019). Nouveaux traitements dans la NASH. Journées Francophones de Nutrition (JFN) 2019, Rennes.

https://research.dial.uclouvain.be/handle/2078.5/169806

Lanthier, N. (2019). La nutrition du patient cirrhotique: quels bénéfices? Entretiens de Nutrition Clinique, Hargimont.

https://research.dial.uclouvain.be/handle/2078.5/164579

2018

Article de journal

Restellini, S., Goossens, N., Clément, S., Lanthier, N., Negro, F., Rubbia-Brandt, L., & Spahr, L. (2018). Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease. World Journal of Hepatology, 10(1), 73-81. https://doi.org/10.4254/wjh.v10.i1.73 (Original work published 2018)

https://research.dial.uclouvain.be/handle/2078.5/174229

Lanthier, N. (2018). La NASH en 2018. Louvain médical, 137(5), 308-313. (Original work published 2018)

https://research.dial.uclouvain.be/handle/2078.5/232566

Francque, S., Lanthier, N., Verbeke, L., Reynaert, H., van Steenkiste, C., Vonghia, L., Kwanten, W. J., Weyler, J., Trépo, E., Cassiman, D., Smets, F., Komuta, M., Dirinck, E., Danse, E., Op de Beeck, B., van Creanenbroeck, E., Van Nieuwenhove, T., Hubens, G., Geerts, A., et al. (2018). The Belgian Association for Study of the Liver guidance document on the management of non-alcoholic fatty liver disease. Acta Gastro-Enterologica Belgica, 81(1), 55-81. (Original work published 2018)

https://research.dial.uclouvain.be/handle/2078.5/174720

Moreels, T., & Lanthier, N. (2018). The quest for quality. Acta Gastro-Enterologica Belgica, 81(1), 3-4. (Original work published 2018)

https://research.dial.uclouvain.be/handle/2078.5/174230

Hamoir, C., de Vos, M., Clinckart, F., Nicaise, G., Komuta, M., & Lanthier, N. (2018). Hepatobiliary and Pancreatic: Nivolumab-related cholangiopathy. Journal of gastroenterology and hepatology, 33(10), 1695. https://doi.org/10.1111/jgh.14136 (Original work published 2018)

https://research.dial.uclouvain.be/handle/2078.5/170855

Lanthier, N. (2018). Haemopoietic stem cell therapy in cirrhosis: the end of the story? The Lancet Gastroenterology and Hepatology, 3, 3-5. https://doi.org/10.1016/S2468-1253(17)30359-X (Original work published 2018)

https://research.dial.uclouvain.be/handle/2078.5/177407

Yildiz, H., Vandercam, B., Thissen, X., Komuta, M., Lanthier, N., Debiève, F., & Dahlqvist, G. (2018). Hepatitis during pregnancy: A case of hemophagocytic lymphohistiocytosis. Clinics and Research in Hepatology and Gastroenterology, 42(3), e49-e55. https://doi.org/10.1016/j.clinre.2017.10.007 (Original work published 2018)

https://research.dial.uclouvain.be/handle/2078.5/172292

Papier de conférence

Lanthier, N. (2018). La NASH: de nouveaux facteurs protecteurs? Entretiens de Nutrition Clinique, Hargimont.

https://research.dial.uclouvain.be/handle/2078.5/164581

Rodriguez, J., Neyrinck, A., Le Roy, T., Leclercq, S., Hiel, S., Cani, P., Lanthier, N., Thissen, J.-P., Bindels, L., & Delzenne, N. (2018). Implication of the gut microbiota in personalized metabolic response to dietary inulin in obese patients. Clinical Nutrition, 37(Suppl 1), S148. https://doi.org/10.1016/j.clnu.2018.06.1548 (Original work published 2018)

https://research.dial.uclouvain.be/handle/2078.5/243963

Etienne, Q., & Lanthier, N. (2018). Fetuin-A is secreted by hepatocytes rather than adipocytes during NAFLD-NASH development in mice and humans and correlates with insulin resistance. Belgian Association for the Study of Obesity (BASO) free communications meeting, Antwerpen.

https://research.dial.uclouvain.be/handle/2078.5/174646

Lanthier, N. (2018). The role of the liver in insulin resistance: focus on hepatic macrophages and fetuin-A. Louvain Drug Research Institute (LDRI) seminar, Brussels.

https://research.dial.uclouvain.be/handle/2078.5/164578

Lanthier, N. (2018). Le bilan somatique du patient alcoolique: un outil d’interrogation et/ou de motivation? Forum Addiction et Société, Bruxelles.

https://research.dial.uclouvain.be/handle/2078.5/167046

2017

Article de journal

Lanthier, N., Lin-Marq, N., Rubbia-Brandt, L., Clément, S., Goossens, N., & Spahr, L. (2017). Autologous bone marrow-derived cell transplantation in decompensated alcoholic liver disease: what is the impact on liver histology and gene expression patterns? Stem Cell Research & Therapy, 8(1), 88 [1-10]. https://doi.org/10.1186/s13287-017-0541-2 (Original work published 2017)

https://research.dial.uclouvain.be/handle/2078.5/178780

Lanthier, N., & Starkel, P. (2017). Treatment of severe alcoholic hepatitis: past, present and future. European Journal of Clinical Investigation, 47(7), 531-539. https://doi.org/10.1111/eci.12767 (Original work published 2017)

https://research.dial.uclouvain.be/handle/2078.5/178787

Papier de conférence

Lanthier, N. (2017). Les nouveaux traitements dans la stéatohépatite non-alcoolique. Livre de résumé des présentations, 2, 29-32. (Original work published 2017)

https://research.dial.uclouvain.be/handle/2078.5/175944

Lanthier, N., & Spahr, L. (2017). Autologous hematopoietic stem cell transplantation into the liver in alcoholic hepatitis: what is the impact on liver histology and gene expression patterns? Acta Gastro-Enterologica Belgica, 80(1), A03. (Original work published 2017)

https://research.dial.uclouvain.be/handle/2078.5/178134

Lanthier, N., Horsmans, Y., & Leclercq, I. (2017). Lipid, fetuin-A and macrophage zonation in high fat diet foz-foz mice with non-alcoholic steatohepatitis. Acta Gastro-Enterologica Belgica, 80(1), A07. (Original work published 2017)

https://research.dial.uclouvain.be/handle/2078.5/178144

Lanthier, N. (2017). How to diagnose NASH: invasive versus non-invasive techniques. Belgian Association for the Study of the Liver (BASL) winter meeting, Gent.

https://research.dial.uclouvain.be/handle/2078.5/174542

2016

Article de journal

Sacré, A., Lanthier, N., Dano, H., Aydin, S., Leggenhager, D., Weber, A., Dekairelle, A.-F., De Cuyper, A., Gala, J.-L., Humblet, Y., Sempoux, C., & Van den Eynde, M. (2016). Regorafenib induced severe toxic hepatitis: characterization and discussion. Liver International, 36(11), 1590-1594. https://doi.org/10.1111/liv.13217 (Original work published 2016)

https://research.dial.uclouvain.be/handle/2078.5/178808

Van Leeuw, J.-B., Berra, E., Gu, Y., Petit, T., Lacroix, V., Lanthier, N., Van Hoof, M., Staessen, J. A., & Persu, A. (2016). Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension? Journal of Hypertension, 34(8), 1659-1661. https://doi.org/10.1097/HJH.0000000000000997 (Original work published 2016)

https://research.dial.uclouvain.be/handle/2078.5/178804

Lanthier, N., & Spahr, L. (2016). SPINK1, macrophages et cellules progénitrices du foie: de nouvelles pistes pour stimuler la régénération dans l’hépatite alcoolique? M/S : médecine sciences, 32(2), 149-152. https://doi.org/10.1051/medsci/20163202005 (Original work published 2016)

https://research.dial.uclouvain.be/handle/2078.5/183090

Papier de conférence

Wuestenberghs, F., Lanthier, N., & Dahlqvist, G. (2016). Impact of nutritional status on cirrhotic inpatients’ prognosis: a retrospective monocentric study. Acta Gastro-Enterologica Belgica, 79(1), A24. (Original work published 2016)

https://research.dial.uclouvain.be/handle/2078.5/183098

Lanthier, N. (2016). Treatment of acute alcoholic hepatitis. Falk Symposium 205: New Treatment Targets in Gut and Liver Diseases, Lucerne.

https://research.dial.uclouvain.be/handle/2078.5/181315

2015

Article de journal

Lanthier, N., Starkel, P., & Horsmans, Y. (2015). New imaging assisted methods for liver fibrosis quantification: is it really favorable to classical transient elastrography ? Journal of Hepatology, 63(3), 765-766. https://doi.org/10.1016/j.jhep.2015.04.027 (Original work published 2015)

https://research.dial.uclouvain.be/handle/2078.5/189898

Ngoma, P. d. J., Kabamba-Mukadi, B., Dahlqvist, G., Sempoux, C., Lanthier, N., Shindano, T., Van Den Neste, E., & Horsmans, Y. (2015). Occult HBV reactivation induced by ibrutinib treatment : a case report. Acta Gastro-Enterologica Belgica, 78(4), 424-426. (Original work published 2015)

https://research.dial.uclouvain.be/handle/2078.5/186904

Lanthier, N. (2015). Targeting Kupffer cells in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why and how? World Journal of Hepatology, 7(19), 2184-2188. https://doi.org/10.4254/wjh.v7.i19.2184 (Original work published 2015)

https://research.dial.uclouvain.be/handle/2078.5/189892

Lanthier, N., Rubbia-Brandt, L., Lin-Marcq, N., Clément, S., Frossard, J.-L., Goossens, N., Hadengue, A., & Spahr, L. (2015). Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis. Journal of Hepatology, 63(3), 609-621. https://doi.org/10.1016/j.jhep.2015.04.003 (Original work published 2015)

https://research.dial.uclouvain.be/handle/2078.5/189910

Poekes, L., Lanthier, N., & Leclercq, I. (2015). Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome. Clinical Science, 129(11), 933-949. https://doi.org/10.1042/CS20150339 (Original work published 2015)

https://research.dial.uclouvain.be/handle/2078.5/187686

Papier de conférence

Lanthier, N. (2015). Les scores d’activité et leur impact sur la prise en charge des patients en hépatologie. Syllabus de la Société Royale Belge de Gastro-Entérologie. Published. Société Royale Belge de Gastro-Entérologie, La Hulpe.

https://research.dial.uclouvain.be/handle/2078.5/235098

Degré, D., & Moreno, C. (2015). Safety and efficacy of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: the Belgian experience. Acta Gastro-Enterologica Belgica (Multilingual Edition), 78(1), A03. (Original work published 2015)

https://research.dial.uclouvain.be/handle/2078.5/190997

2014

Article de journal

Lanthier, N., & Leclercq, I. (2014). Adipose tissues as endocrine target organs. Bailliere’s Best Practice & Research: Clinical Gastroenterology, 28(4), 545-558. https://doi.org/10.1016/j.bpg.2014.07.002 (Original work published 2014)

https://research.dial.uclouvain.be/handle/2078.5/198227

Lanthier, N., & Leclercq, I. (2014). Liver and systemic insulin resistance. Hepatology, 60(3), 1113-1114. https://doi.org/10.1002/hep.27017 (Original work published 2014)

https://research.dial.uclouvain.be/handle/2078.5/201482

Lanthier, N. (2014). The role of the liver in insulin resistance. Treatment Strategies - Hepatology, 1(1), 89-95. (Original work published 2014)

https://research.dial.uclouvain.be/handle/2078.5/198568

Papier de conférence

Starkel, P., Lanthier, N., & Horsmans, Y. (2014). Activation of interferon and NF-kB pathways in early human alcoholic liver disease development. Acta Gastro-Enterologica Belgica, 77(1), A03. (Original work published 2014)

https://research.dial.uclouvain.be/handle/2078.5/198603

2013

Article de journal

Lanthier, N., Rubbia-Brandt, L., & Spahr, L. (2013). Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseases. Acta Gastro-Enterologica Belgica, 76(1), 3-9. (Original work published 2013)

https://research.dial.uclouvain.be/handle/2078.5/204144

Spahr, L., Chalandon, Y., Terraz, S., Kindler, V., Rubbia-Brandt, L., Frossard, J.-L., Breguet, R., Lanthier, N., Farina, A., Passweg, J., Becker, C. D., & Hadengue, A. (2013). Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial. PLoS One, 8(1), e53719. https://doi.org/10.1371/journal.pone.0053719 (Original work published 2013)

https://research.dial.uclouvain.be/handle/2078.5/204146

Lebrun, V., Molendi-Coste, O., Lanthier, N., Sempoux, C., Cani, P., van Rooijen, N., Starkel, P., Horsmans, Y., & Leclercq, I. (2013). Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice. Clinical Science, 125(11), 501-511. https://doi.org/10.1042/CS20130064 (Original work published 2013)

https://research.dial.uclouvain.be/handle/2078.5/204208

Papier de conférence

Lanthier, N., & Spahr, L. (2013). High liver expression of SPINK-1 is associated with progenitor cell and hepatocyte proliferation and determines MELD score improvement in decompensated alcoholic liver disease. Journal of Hepatology, 58(S1), S54. (Original work published 2013)

https://research.dial.uclouvain.be/handle/2078.5/201527

Lanthier, N., Lebrun, V., Molendi-Coste, O., & Leclercq, I. (2013). High fat induced insulin resistance: the emerging role of hepatokines. BASO Free communications meetings, UZ Brussels.

https://research.dial.uclouvain.be/handle/2078.5/167208

Lanthier, N., & Leclercq, I. (2013). High fat induced insulin resistance: the emerging role of hepatokines. Acta Gastro-Enterologica Belgica, 76(1), A16. (Original work published 2013)

https://research.dial.uclouvain.be/handle/2078.5/201501

Lanthier, N., Rubbia-Brandt, L., Lin-Marq, N., Chalandon, Y., Frossard, J.-L., & Spahr, L. (2013). Liver cell proliferation determines MELD score improvement in decompensated alcoholic liver disease. Acta Gastro-Enterologica Belgica, 76(1), A11. (Original work published 2013)

https://research.dial.uclouvain.be/handle/2078.5/213596

Lanthier, N., Terraz, S., Breguet, R., & Spahr, L. (2013). Computed tomography derived liver volume: a prognostic factor in decompensated alcoholic cirrhosis? Acta Gastro-Enterologica Belgica, 76(1), 12. (Original work published 2013)

https://research.dial.uclouvain.be/handle/2078.5/201515

2012

Article de journal

Lanthier, N., Terraz, S., & Frossard, J.-L. (2012). An unusual cause of cholecystitis. Gastroenterology, 143(6), e9-e10. https://doi.org/10.1053/j.gastro.2012.07.010 (Original work published 2012)

https://research.dial.uclouvain.be/handle/2078.5/159048

Cao, D. T., Reny, J.-L., Lanthier, N., & Frossard, J.-L. (2012). Intramural Hematoma of the Esophagus. Case Reports in Gastroenterology, 6(2), 510-517. https://doi.org/10.1159/000341808 (Original work published 2012)

https://research.dial.uclouvain.be/handle/2078.5/194419

Goossens, N., Ditisheim, S., Lanthier, N., Spahr, L., & Hadengue, A. (2012). Alcoholic steatohepatitis: what’s new in 2012? Revue Médicale Suisse, 8(352), 1646-1648. (Original work published 2012)

https://research.dial.uclouvain.be/handle/2078.5/206082

Papier de conférence

Lanthier, N., Hadengue, A., & Spahr, L. (2012). Proliferative activity in CK7 positive cells and hepatocytes as well as macrophage expansion predict MELD score improvement in decompensated alcoholic liver disease (ALD). Swiss Medical Weekly, 142(Suppl 194), 4S. (Original work published 2012)

https://research.dial.uclouvain.be/handle/2078.5/201353

Poekes, L., Lanthier, N., Farrell, G. C., Leclercq, I., & Legry, V. (2012). Role of inflammation and insulin resistance in a new model of NASH: the foz/foz mice. Acta Gastro-Enterologica Belgica (Multilingual Edition), 75(1), A11. (Original work published 2012)

https://research.dial.uclouvain.be/handle/2078.5/207068

Lanthier, N., & Spahr, L. (2012). Fibrosis quantification in alcoholic liver disease: a histological-hemodynamic study. Swiss Medical Weekly, 142(Suppl 194), 14S. (Original work published 2012)

https://research.dial.uclouvain.be/handle/2078.5/201346

Lanthier, N., Rubbia-Brandt, L., Hadengue, A., & Spahr, L. (2012). Bone marrow mononuclear cell infusion into the liver is associated with liver macrophage expansion in patients with decompendated alcoholic liver disease (ALD). Swiss Medical Weekly, 142(Suppl 194), 14S. (Original work published 2012)

https://research.dial.uclouvain.be/handle/2078.5/201349

Lanthier, N., Rubbia-Brandt, L., Kindler, V., Hadengue, A., & Spahr, L. (2012). Differential hepatic gene expression profiles identify improvement in MELD score following decompensation in alcoholic liver disease. Hepatology, 56(S1), 982A. (Original work published 2012)

https://research.dial.uclouvain.be/handle/2078.5/201491

2011

Article de journal

Van Hul, N., Lanthier, N., Espanol Suner, R., Abarca-Quinones, J., van Rooijen, N., & Leclercq, I. (2011). Kupffer cells influence parenchymal invasion and phenotypic orientation, but not the proliferation, of liver progenitor cells in a murine model of liver injury. The American Journal of Pathology : cellular and molecular biology of disease, 179(4), 1839-1850. https://doi.org/10.1016/j.ajpath.2011.06.042 (Original work published 2011)

https://research.dial.uclouvain.be/handle/2078.5/209596

Lanthier, N., Molendi-Coste, O., Cani, P., van Rooijen, N., Horsmans, Y., & Leclercq, I. (2011). Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet. The FASEB Journal, 25(12), 4301-4311. https://doi.org/10.1096/fj.11-189472 (Original work published 2011)

https://research.dial.uclouvain.be/handle/2078.5/209567

Papier de conférence

Lanthier, N., Molendi-Coste, O., Horsmans, Y., & Leclercq, I. (2011). Does TLR4 participate to the early activation of Kupffer cells elicited by a high fat diet ? Hepatology, 54(4), 1174A. (Original work published 2011)

https://research.dial.uclouvain.be/handle/2078.5/161374

2010

Papier de conférence

Van Hul, N., Lanthier, N., & Leclercq, I. (2010). Liver progenitor cell expansion in the injured mouse liver: Do Kupffer cells play a role? Belgian Week of Gastroenterology Abstract Book, p. 12.

https://research.dial.uclouvain.be/handle/2078.5/161131

Lanthier, N., Molendi-Coste, O., Cani, P., Horsmans, Y., & Leclercq, I. (2010). Cross-talk between Kupffer cells and adipose tissue in the pathogenesis of insulin resistance. Hepatology, 52(5), 1045A. (Original work published 2010)

https://research.dial.uclouvain.be/handle/2078.5/160995

Article de journal

Lanthier, N., Molendi-Coste, O., Horsmans, Y., van Rooijen, N., Cani, P., & Leclercq, I. (2010). Kupffer cell activation is a causal factor for hepatic insulin resistance. American Journal of Physiology: Gastrointestinal and Liver Physiology, 298(1), G107-116. https://doi.org/10.1152/ajpgi.00391.2009 (Original work published 2010)

https://research.dial.uclouvain.be/handle/2078.5/131923

Gerin, I., Clerbaux, L.-A., Haumont, O., Lanthier, N., Das, A. K., Burant, C. F., Leclercq, I., MacDougald, O. A., & Bommer, G. (2010). Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. Journal of Biological Chemistry, 285(44), 33652-33661. https://doi.org/10.1074/jbc.M110.152090 (Original work published 2010)

https://research.dial.uclouvain.be/handle/2078.5/274842

2009

Papier de conférence

Lanthier, N., Horsmans, Y., Molendi-Coste, O., Lebrun, V., Petit, M., Cani, P., & Leclercq, I. (2009). Kupffer Cell Activation Participates in the Initiation of High Fat Diet-induced Hepatic Insulin Resistance. Hepatology, 50(4), 1177A-1177A. (Original work published 2009)

https://research.dial.uclouvain.be/handle/2078.5/147232

Lanthier, N., Petit, M., Pèlerin, H., Abarca-Quinones, J., Lebrun, V., Molendi-Coste, O., Campard, D., Horsmans, Y., & Leclercq, I. (2009). Kupffer cell depletion improves hepatic insulin sensitivity. Acta Gastro-Enterologica Belgica (Multilingual Edition), 72(1), A11. (Original work published 2009)

https://research.dial.uclouvain.be/handle/2078.5/31587

Lanthier, N., Molendi-Coste, O., Horsmans, Y., Cani, P., & Leclercq, I. (2009). Liver and adipose tissue macrophage depletion improves hepatic insulin sensitivity. Basic science workshop syllabus, p. 32.

https://research.dial.uclouvain.be/handle/2078.5/232272

Article de journal

Lanthier, N., & Leclercq, I. (2009). Adiponectin in non-alcoholic steatohepatitis: an ideal culprit, but what are the proofs of its guilt? Journal of gastroenterology and hepatology, 24(10), 1584-1586. https://doi.org/10.1111/j.1440-1746.2009.06087.x (Original work published 2009)

https://research.dial.uclouvain.be/handle/2078.5/123977

Lanthier, N., Horsmans, Y., & Leclercq, I. (2009). The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis. Current Opinion in Clinical Nutrition and Metabolic Care, 12(4), 404-411. https://doi.org/10.1097/MCO.0b013e32832c7819 (Original work published 2009)

https://research.dial.uclouvain.be/handle/2078.5/131062

Pierard, S., Coche, J.-C., Lanthier, P., Dekoninck, X., Lanthier, N., Rahier, J., & Geubel, A. (2009). Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. European Journal of Gastroenterology and Hepatology, 21(8), 941-945. https://doi.org/10.1097/MEG.0b013e3283155451 (Original work published 2009)

https://research.dial.uclouvain.be/handle/2078.5/210106

Lanthier, N., Horsmans, Y., & Leclercq, I. (2009). Clodronate liposomes: All sites of injection are not equal. Hepatology (Baltimore, Md.), 51(2), 721-2; author reply 722. https://doi.org/10.1002/hep.23455 (Original work published 2010)

https://research.dial.uclouvain.be/handle/2078.5/129037

2008

Papier de conférence

Lanthier, N., Van Hul, N., Abarca-Quinones, J., Lebrun, V., Sempoux, C., Horsmans, Y., & Leclercq, I. (2008). After short-term exposure of mice to a high fat diet, F4/80 positive macrophages are preferentially found in the vicinity of lipid-loaded hepatocytes. Acta Gastro-Enterologica Belgica, 71(1), A04. (Original work published 2008)

https://research.dial.uclouvain.be/handle/2078.5/31595

Lanthier, N., Van Hul, N., Abarca-Quinones, J., Lebrun, V., Petit, M., Sempoux, C., Horsmans, Y., & Leclercq, I. (2008). High fat feeding induces hepatic insulin resistance and preferential distribution of Kupffer cells around lipid loaded hepatocytes. Gut, 57(10), A43. (Original work published 2008)

https://research.dial.uclouvain.be/handle/2078.5/160998

2006

Papier de conférence

Kersten, V., Lanthier, N., Descamps, O., Semeria, S., Marcovitch, O., & de Meester, A. (2006). Clinical and echocardiographic data predict diagnosis in patients younger than 40 years admitted for chest pain and elevated troponin I levels. Acta Clinica Belgica, 61(5), 304. (Original work published 2006)

https://research.dial.uclouvain.be/handle/2078.5/119266

2005

Article de journal

Lanthier, N., Parc, C., Scavennec, R., Dhôte, R., Brézin, A., Guillevin, L., & et al. (2005). Infliximab in the treatment of posterior uveitis in Behçet’s disease. Long term follow up in four patients. La Presse Médicale, 34(13), 916-918. https://doi.org/10.1016/S0755-4982(05)84079-5 (Original work published 2005)

https://research.dial.uclouvain.be/handle/2078.5/160545

Lanthier, N. (2005). Nouvelle perspective thérapeutique de l’insuffisance cardiaque. Louvain médical, 124(1), 39-44. (Original work published 2005)

https://research.dial.uclouvain.be/handle/2078.5/30661

Année	Libellé	Établissement
2025	Basic in clinical sports nutrition	The European Society for Clinical Nutrition and Metabolism (Belgique)
2017	Certificat de compétence pour l'utilisation de rayons X en diagnostic médical	UCLouvain \| Université catholique de Louvain (Belgique)
2013	Docteur en sciences biomédicales et pharmaceutiques	UCLouvain \| Université catholique de Louvain (Belgique)
2012	Master complémentaire en gastro-entérologie	UCLouvain \| Université catholique de Louvain (Belgique)
2005	Docteur en médecine	UCLouvain \| Université catholique de Louvain (Belgique)
2004	Certificat de compétence en électrocardiographie	UCLouvain \| Université catholique de Louvain (Belgique)

Unités d'enseignement pour 2026

Libellé	Code
Compléments de gastro-entérologie	WINTR2260
Physiopathologie de la nutrition	WSBIM2134
Innovation and research in nutrition	WSBIM2138

Menu

Nicolas Lanthier

Adresse postale

MEDE -- IREC/GAEN Pôle d'Hépato-gastroentérologi

MEDE -- Faculté de médecine et science dentaire

Réseaux sociaux

Unités d'enseignement pour 2026